Foundation Medicine Liquid
FoundationOne Liquid CDx is a blood-based comprehensive genomic profiling test when tissue is unavailable or insufficient.
Get started with Foundation Medicine Liquid
How to get started
Upload your records
Pathology, genomics, imaging — whatever you have. We extract the clinical details automatically so nothing gets retyped. Upload records →
Share with Foundation Medicine Liquid
We package your records into a secure, HIPAA-compliant bundle and pre-fill the intake. You review and sign — that's it. Share records →
Foundation Medicine Liquid reaches out
Their team confirms next steps directly with you — testing, scheduling, consultation, or enrollment.
About this service
FoundationOne Liquid CDx is a blood-based comprehensive genomic profiling test when tissue is unavailable or insufficient.
FoundationOne Liquid CDx
Coverage, insurance & cost
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Foundation Medicine Liquid handles billing.
Accepted
Available
Required
In-network carriers
Who this is for
Cancer types served
Common questions in this category
Based on what other patients have asked.
When is a pet/ct scan advised for a new breast cancer diagnosis
Breast CancerDoes the specific variant of the CHEk2 mutation make a difference? I have the Ashkenazi Founder variant.
Is the CHEK2 mutation related to prostate cancer
What lifestyle changes are recommended for Prostate - Early Stage patients
Prostate - Early StageWhat should I know as a newly diagnosed CRC patient
Colorectal CancerWhat should I ask my oncologist after a new diagnosis
Also consider
Other providers in similar categories.
Tempus
5 offeringsTempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Foundation Medicine
4 offeringsFoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Invitae
2 offeringsInvitae offers genetic testing for hereditary cancer syndromes including BRCA1/2, Lynch syndrome, and other inherited cancer risks.
Guardant Health
Guardant360 is a comprehensive liquid biopsy test that analyzes ctDNA to identify genomic alterations and guide treatment decisions.
Get personalized guidance for your case
This page is general information. Upload your records for analysis specific to YOUR diagnosis.